Home > Publications Database > Nonvesicular lipid transfer drives myelin growth in the central nervous system. > print |
001 | 273899 | ||
005 | 20250120165732.0 | ||
024 | 7 | _ | |a 10.1038/s41467-024-53511-y |2 doi |
024 | 7 | _ | |a pmid:39528474 |2 pmid |
024 | 7 | _ | |a pmc:PMC11554831 |2 pmc |
024 | 7 | _ | |a altmetric:170311338 |2 altmetric |
037 | _ | _ | |a DZNE-2024-01378 |
041 | _ | _ | |a English |
082 | _ | _ | |a 500 |
100 | 1 | _ | |a Wu, Jianping |0 P:(DE-2719)9000820 |b 0 |e First author |
245 | _ | _ | |a Nonvesicular lipid transfer drives myelin growth in the central nervous system. |
260 | _ | _ | |a [London] |c 2024 |b Nature Publishing Group UK |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1737365288_4999 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Oligodendrocytes extend numerous cellular processes that wrap multiple times around axons to generate lipid-rich myelin sheaths. Myelin biogenesis requires an enormously productive biosynthetic machinery for generating and delivering these large amounts of newly synthesized lipids. Yet, a complete understanding of this process remains elusive. Utilizing volume electron microscopy, we demonstrate that the oligodendroglial endoplasmic reticulum (ER) is enriched in developing myelin, extending into and making contact with the innermost myelin layer where growth occurs. We explore the possibility of transfer of lipids from the ER to myelin, and find that the glycolipid transfer protein (GLTP), implicated in nonvesicular lipid transport, is highly enriched in the growing myelin sheath. Mice with a specific knockout of Gltp in oligodendrocytes exhibit ER pathology, hypomyelination and a decrease in myelin glycolipid content. In summary, our results demonstrate a role for nonvesicular lipid transport in CNS myelin growth, revealing a cellular pathway in developmental myelination. |
536 | _ | _ | |a 351 - Brain Function (POF4-351) |0 G:(DE-HGF)POF4-351 |c POF4-351 |f POF IV |x 0 |
536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 1 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
650 | _ | 7 | |a Carrier Proteins |2 NLM Chemicals |
650 | _ | 7 | |a Glycolipids |2 NLM Chemicals |
650 | _ | 7 | |a lipid transfer protein |2 NLM Chemicals |
650 | _ | 2 | |a Animals |2 MeSH |
650 | _ | 2 | |a Myelin Sheath: metabolism |2 MeSH |
650 | _ | 2 | |a Oligodendroglia: metabolism |2 MeSH |
650 | _ | 2 | |a Oligodendroglia: cytology |2 MeSH |
650 | _ | 2 | |a Mice |2 MeSH |
650 | _ | 2 | |a Central Nervous System: metabolism |2 MeSH |
650 | _ | 2 | |a Central Nervous System: growth & development |2 MeSH |
650 | _ | 2 | |a Mice, Knockout |2 MeSH |
650 | _ | 2 | |a Endoplasmic Reticulum: metabolism |2 MeSH |
650 | _ | 2 | |a Carrier Proteins: metabolism |2 MeSH |
650 | _ | 2 | |a Carrier Proteins: genetics |2 MeSH |
650 | _ | 2 | |a Lipid Metabolism |2 MeSH |
650 | _ | 2 | |a Glycolipids: metabolism |2 MeSH |
650 | _ | 2 | |a Mice, Inbred C57BL |2 MeSH |
650 | _ | 2 | |a Biological Transport |2 MeSH |
700 | 1 | _ | |a Kislinger, Georg |0 P:(DE-2719)9000614 |b 1 |
700 | 1 | _ | |a Duschek, Jerome |0 P:(DE-2719)9003122 |b 2 |u dzne |
700 | 1 | _ | |a Durmaz, Ayşe Damla |0 P:(DE-2719)9002505 |b 3 |u dzne |
700 | 1 | _ | |a Wefers, Benedikt |0 P:(DE-2719)2810988 |b 4 |
700 | 1 | _ | |a Feng, Ruoqing |0 P:(DE-2719)9002625 |b 5 |u dzne |
700 | 1 | _ | |a Nalbach, Karsten |0 P:(DE-2719)9002811 |b 6 |u dzne |
700 | 1 | _ | |a Wurst, Wolfgang |0 P:(DE-2719)2000028 |b 7 |
700 | 1 | _ | |a Behrends, Christian |0 0000-0002-9184-7607 |b 8 |
700 | 1 | _ | |a Schifferer, Martina |0 P:(DE-2719)2812260 |b 9 |
700 | 1 | _ | |a Simons, Mikael |0 P:(DE-2719)2811642 |b 10 |e Last author |u dzne |
773 | _ | _ | |a 10.1038/s41467-024-53511-y |g Vol. 15, no. 1, p. 9756 |0 PERI:(DE-600)2553671-0 |n 1 |p 9756 |t Nature Communications |v 15 |y 2024 |x 2041-1723 |
787 | 0 | _ | |a Wu, Jianping |d Zenodo, 2024 |i RelatedTo |0 DZNE-2024-01349 |r |t Dataset: Lipidomics of myelin from wild-type and Gltp cKO mice, v1 |
856 | 4 | _ | |u https://pub.dzne.de/record/273899/files/DZNE-2024-01378%20SRC.csv |
856 | 4 | _ | |u https://pub.dzne.de/record/273899/files/DZNE-2024-01378%20SRC.ods |
856 | 4 | _ | |u https://pub.dzne.de/record/273899/files/DZNE-2024-01378%20SRC.xls |
856 | 4 | _ | |u https://pub.dzne.de/record/273899/files/DZNE-2024-01378%20SRC.xlsx |
856 | 4 | _ | |u https://pub.dzne.de/record/273899/files/DZNE-2024-01378%20SUP.zip |
856 | 4 | _ | |u https://pub.dzne.de/record/273899/files/DZNE-2024-01378.pdf |y OpenAccess |
856 | 4 | _ | |u https://pub.dzne.de/record/273899/files/DZNE-2024-01378.pdf?subformat=pdfa |x pdfa |y OpenAccess |
909 | C | O | |o oai:pub.dzne.de:273899 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)9000820 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)9000614 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 2 |6 P:(DE-2719)9003122 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)9002505 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2810988 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 5 |6 P:(DE-2719)9002625 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 6 |6 P:(DE-2719)9002811 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 7 |6 P:(DE-2719)2000028 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2812260 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 10 |6 P:(DE-2719)2811642 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-351 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Brain Function |x 0 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 1 |
914 | 1 | _ | |y 2024 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-08-29 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2023-08-29 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1060 |2 StatID |b Current Contents - Agriculture, Biology and Environmental Sciences |d 2023-08-29 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-05-02T09:09:09Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-08-29 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2023-08-29 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-08-29 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |d 2023-08-29 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2023-08-29 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-29 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-08-29 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT COMMUN : 2022 |d 2023-08-29 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-05-02T09:09:09Z |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-29 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-08-29 |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b NAT COMMUN : 2022 |d 2023-08-29 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-08-29 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Peer review |d 2023-05-02T09:09:09Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-08-29 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-08-29 |
920 | 1 | _ | |0 I:(DE-2719)1110008 |k AG Simons |l Molecular Neurobiology |x 0 |
920 | 1 | _ | |0 I:(DE-2719)1140001 |k AG Wurst |l Genome Engineering |x 1 |
920 | 1 | _ | |0 I:(DE-2719)1110000-4 |k AG Misgeld |l Neuronal Cell Biology |x 2 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-2719)1110008 |
980 | _ | _ | |a I:(DE-2719)1140001 |
980 | _ | _ | |a I:(DE-2719)1110000-4 |
980 | _ | _ | |a UNRESTRICTED |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|